Figure 1.

Drug-based and non-drug-based symptomatic treatment approaches for MS complement each other in almost every stage of disease. Drug-based strategies encompass basic treatments (interferon-β or glatriameracetete) and -- if these drugs are not sufficiently effective -- escalation therapy with immunosuppressive substances (mitoxantrone), monoclonal antibodies (natalizumab) or sphingosinphosphat receptor modulator fingolimod. Non-drug strategies like physical therapy (physiotherapy, ergotherapy, logopedics, rehabilitaton) and occupational therapy (sociotherapy and psychotherapy) are used complementarily in all stages of the disease